D-Dimer Testing in Clinical Practice

Primary Recommendations

The American Society of Hematology recommends D-dimer testing should be used exclusively as a rule-out test in patients with low clinical probability of venous thromboembolism (VTE), where a negative highly sensitive D-dimer result safely excludes DVT or PE without further imaging 1, 2

For patients with low clinical probability of VTE (≤10% prevalence), the American College of Chest Physicians suggests starting with highly sensitive D-dimer testing (ELISA-based assays preferred with 96% sensitivity) 1, 2
A negative D-dimer result can stop further testing, as no DVT/PE is present, and no further anticoagulation is required 1, 2
For patients with intermediate clinical probability (~15-25% prevalence), whole-leg ultrasound or proximal compression ultrasound may be considered directly, as D-dimer utility decreases as prevalence increases 1

Hospitalized patients have limited utility of D-dimer due to high frequency of positive results regardless of VTE status 1, 2
Post-surgical patients have unreliable standard thresholds for D-dimer 1
Pregnant patients have physiologic elevation of D-dimer, though normal values still exclude PE 3
Cancer patients frequently have elevated D-dimer without thrombosis 2

For patients over 50 years, using age-adjusted cutoff (age × 10 μg/L) can improve specificity while maintaining safety 2, 3

D-dimer has lower certainty evidence for suspected recurrent DVT, with sensitivity of 97% and specificity of 99% in limited studies 1
Serial ultrasound remains the preferred approach for suspected recurrent DVT 1, 4

D-dimer has limited but potential utility in CVT exclusion, with normal D-dimer by sensitive immunoassay or rapid ELISA helping to identify low-probability CVT patients 5

A positive D-dimer cannot confirm thrombosis, and imaging confirmation is mandatory before initiating anticoagulation 1, 2
Specificity of D-dimer is only 35-47% for VTE, and multiple non-thrombotic conditions can elevate D-dimer 1, 3

No anticoagulation is warranted when imaging is negative, as the negative predictive value of normal imaging effectively excludes clinically significant VTE 2
3-month thromboembolism risk is only 0.14% without anticoagulation 2